Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management

with Dr Bruce Trapnell, MD, MS, and Dr Tisha Wang, MD

May 19 @ 1:15 pm 2:00 pm PDT

Innovation Theater 4 (Booth #1450)
Supported By Savara Inc.

On Sunday, May 19, from 1:15 PM to 2:00 PM, we will have two exciting speakers discuss the rare lung disease pulmonary alveolar proteinosis (PAP) during their talk: Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management.

Dr Bruce Trapnell, MD, MS, is a professor of medicine and pediatrics at the University of Cincinnati. He is the co-founder, Scientific Director, and Chairman of the Board of Directors of the PAP Foundation.

Dr Tisha Wang, MD, is a professor of clinical medicine in the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), who also serves as the Clinical Director and VP of the PAP Foundation.

During this engaging discussion:

  • Understand the basic principles of PAP, including pathophysiology and classification
  • Identify signs and symptoms of autoimmune PAP (aPAP), the most common form of PAP
  • Describe the diagnostic approach to aPAP
  • Evaluate current management options for aPAP

Lunch will be provided by the ATS. We hope to see you there!

Bruce Trapnell, MD, MS
University of Cincinnati
Professor of Medicine and Pediatrics
Cincinnati, Ohio

Tisha Wang, MD
University of California
Professor of Clinical Medicine
Los Angeles, CA